Umesh Kathad
Research Subjects
Umesh Kathad has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Aditya Kulkarni
Lantern Pharma Inc., Dallas, Texas
76 shared publications - Kishor Bhatia
Lantern Pharma Inc., Dallas, Texas
76 shared publications - Panna Sharma
Lantern Pharma Inc., Dallas, Texas
66 shared publications - Jianli Zhou
Lantern Pharma Inc., Dallas, Texas
57 shared publications - Kamil Solarczyk
3intoDNA S.A. Kraków, Poland
47 shared publications - Neha Biyani
Lantern Pharma Inc., Dallas, Texas
47 shared publications
Latest Publications
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies
Supplementary Table 2 from Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies
Supplementary Table 2 from Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary figures and tables legends from Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies
Supplementary figure legends and Tables
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary figures and tables legends from Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies
Supplementary figure legends and Tables
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies
Supplementary Table 1 from Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies
Supplementary Table 1 from Conditional Dependency of LP-184 on Prostaglandin Reductase 1 is Synthetic Lethal in Pancreatic Cancers with DNA Damage Repair Deficiencies
- Open Access
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Figures 1 from Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma
- 25 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigures 1 from Preclinical Efficacy of LP-184, a Tumor Site Activated Synthetic Lethal Therapeutic, in Glioblastoma
- Open Access
- 12 May 2025
- Published by Qeios Ltd
Review of: "Scalable Antigen-Antibody Binding Affinity Landscape: A Case Study with ENHERTU"
Overall, not enough data and details are provided in the Materials and Methods section. What input data was used for methods like Modeller and Prodigy is not clear from the information provided. Probably, a better workflow diagram showing data flow (...
- 12 May 2025
- Published by Qeios Ltd
Open AccessReview of: "Scalable Antigen-Antibody Binding Affinity Landscape: A Case Study with ENHERTU"
Overall, not enough data and details are provided in the Materials and Methods section. What input data was used for methods like Modeller and Prodigy is not clear from the information provided. Probably, a better workflow diagram showing data flow (...
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from Conditional dependency of LP-184 on prostaglandin reductase 1 is synthetic lethal in pancreatic cancers with DNA damage repair deficiencies
Supplementary Table 2 from Conditional dependency of LP-184 on prostaglandin reductase 1 is synthetic lethal in pancreatic cancers with DNA damage repair deficiencies
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from Conditional dependency of LP-184 on prostaglandin reductase 1 is synthetic lethal in pancreatic cancers with DNA damage repair deficiencies
Supplementary Table 2 from Conditional dependency of LP-184 on prostaglandin reductase 1 is synthetic lethal in pancreatic cancers with DNA damage repair deficiencies